Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immuno
Journal of Clinical Oncology · 20.06.2026 · 44 (18) · 1745-1746
DOI: 10.1200/jco-25-03015 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.06.2026. Verfasst von Yongkai Lu. Beteiligte Einrichtung: Yongkai Lu, MD, Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Yongkai Lu, MD, Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi, China.
Zitieren
APA
Lu, Y. (2026). Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immuno. Journal of Clinical Oncology, 44(18), 1745-1746. https://doi.org/10.1200/jco-25-03015
Vancouver
Lu Y. Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immuno. Journal of Clinical Oncology. 2026;44(18):1745-1746. doi:10.1200/jco-25-03015
BibTeX
@article{Lu2026,
author = {Lu, Yongkai},
title = {Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immuno},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {18},
pages = {1745--1746},
doi = {10.1200/jco-25-03015}
}
EUVIMED